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I. Definition 
Ischemic heart disease due to coronary atherosclerosis is 
uncommon in subjects in their 20s, but its prevalence in•
creases rapidly after the fourth decade of life. It is the most 
frequent cause of death in adults over 45 years of age and 
is probably the most frequent cause of sudden, unexpected 
death in apparently healthy competitive athletes over age 
35 (1-3). 
The diagnosis of coronary atherosclerotic disease can be 
made with a high degree of probability by certain nonin•
vasive findings (for example, a history of acute myocardial 
infarction or a history of angina pectoris associated with an 
abnormal electrocardiogram, ejection fraction or myocardial 
perfusion response to exercise) and more definitively by 
coronary angiography. For the purposes of this Task Force, 
we will consider a subject to have "known" coronary dis•
ease if coronary angiography has been performed and has 
demonstrated "significant" (2::50%) narrowing of one or 
more coronary arteries or if, in the judgment of the phy•
sician, the history and noninvasive studies indicate a high 
probability of coronary atherosclerotic disease. 
We appreciate that a vasospastic component may con•
tribute to the morbidity and mortality of atherosclerotic coro•
nary disease and may occasionally be the sole source of 
ischemia occurring at rest or induced by exercise (4,5). Little 
is known about the natural history of vasospastic disease, 
its precipitating factors and its risk assessment. Conse•
quently, the following discussion applies exclusively to ath•
erosclerotic coronary artery disease. 
Risk assessment. The issue of whether a patient with 
known coronary artery disease should participate in com•
petitive sports relates to how effectively we can define pa•
tients who, despite having coronary atherosclerotic disease, 
would not incur undue risks by their participation. One 
factor bearing on risk assessment is the severity of coronary 
disease. Disease severity can probably best be assessed by: 
I) the degree of left ventricular dysfunction, and 2) the 
presence or absence of inducible ischefTlia. Although no data 
exist specifically relating severity of coronary atheroscle•
rotic disease to risk of participating in competitive athletics, 
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natural history studies have demonstrated that the degree of 
left ventricular dysfunction is directly related to prognosis 
(6,7). Other studies have shown that in patients with mod•
erate to severe symptoms, exercise capacity and the electro•
cardiographic response to exercise provide important prog•
nostic data (8,9), A more recent study (10) has extended 
these observations to asymptomatic or mildly symptomatic 
patients with normal or near normal left ventricular function 
at rest. These data help identify patients at low and at high 
risk of dying. Although it is uncertain whether such prog•
nostic information can be extended to assessing the risks of 
participating in competitive sports, it would not seem un•
reasonable to make such an extrapolation. We therefore have 
used the data derived from natural history studies to estimate 
the risk of participating in competitive sports, and thereby 
to formulate our recommendations. A second factor bearing 
on risk assessment is the intensity of the particular com•
petitive sport, because it is likely that the subject with coro•
nary atherosclerotic disease will be exposed to increasing 
risk with increasing intensity of the proposed athletic 
competition. 
II. Evaluation 
Noninvasive Tests 
I. In all patients with coronary artery disease who are con•
sidering athletic competition, left ventricular systolic 
function at rest should be assessed. This can be per•
formed qualitatively or semiquantitatively by two-di•
mensional echocardiography or quantitatively by gated 
blood pool scintigraphy. 
2. In all patients with normal or near normal left ventricular 
function at rest, treadmill or bicycle exercise testing should 
be performed to assess exercise capacity and to determine 
whether ischemia can be induced. The latter can be de•
termined by exercise electrocardiography (2:: 1 mm ST 
segment depression or elevation developing during or 
just after exercise, when compared with control), gated 
blood pool scintigraphy (ejection fraction decreases be•
low rest value during exercise), thallium perfusion im-
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aging (a definite defect can be seen during exercise, 
which disappears at rest) or sUbjective evidence of isch•
emia (angina). 
Three levels of risk may be defined by noninvasive studies. 
High risk. The patient has decreased left ventricular sys-
tolic function at rest. 
Moderate risk. The patient has normal or near normal 
left ventricular systolic function at rest, but anyone of the 
following factors is also present: I) decreased exercise ca•
pacity (less than 50 years of age, <7 METS or 25 ml 
Oz/kg.min; 50 to 65 years of age, <6 METS or 21 ml 
02/kg.min; greater than 65 years of age, <5 METS or 17.5 
ml 02/kg.min) demonstrated during treadmill or bicycle ex•
ercise testing; 2) evidence of ischemia induced by exercise 
tolerance testing; 3) ventricular tachycardia during or after 
exercise tolerance testing; and 4) decreased systolic arterial 
pressure with an increase in work load during exercise tol•
erance testing. 
Low risk. The patient has normal or near normal left 
ventricular systolic function at rest and also has I) normal 
or near normal exercise capacity (less than 50 years of age, 
"27 METS or 25 ml 02/kg.min; 50 to 65 years of age, "26 
METS or 21 ml 02/kg.min; greater than 65 years of age, 
"25 METS or 17.5 ml 02/kg.min); 2) no evidence of isch•
emia induced by maximal exercise testing, or ischemia only 
at high level exercise; and 3) no ventricular tachycardia 
during or after exercise tolerance testing. 
These levels of risk were developed with the assumption 
that patients undergo evaluation when not receiving cardiac 
medication and before any exercise training programs. It is 
uncertain whether the patient classified in the low risk subgroup 
only when receiving medication or after dynamic exercise 
training has the same low risk as a patient tested in the 
absence of such treatment. Testing the patient who is not 
taking medication and using the results obtained before an 
exercise training program represent the more conservative 
approach to risk assessment. 
Invasive Tests 
Do all patients with coronary atherosclerotic disease need 
coronary angiography, in addition to the previously de•
scribed noninvasive studies, to define risk stratification and 
to help determine whether it would be reasonable for them 
to participate in competitive sports? It is unlikely that any 
patient with left main coronary disease would be included 
in the low risk group as ident;fied by exercise testing. In 
contrast, some patients with triple vessel disease will have 
a good exercise capacity and normal electrocardiographic 
responses to exercise (and also normal radionuclide-derived 
indexes of left ventricular function or perfusion) (10-12). 
It also would appear likely that a subject with triple vessel 
disease would expose himself or herself to a higher risk by 
participating in competitive sports than would a patient with 
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single or double vessel disease. Hence, this might pose a 
compelling argument for subjecting all patients with coro•
nary atherosclerotic disease, regardless of their noninvasive 
risk assessment, to coronary angiography. However, normal 
electrocardiographic, left ventricular function and left ven•
tricular perfusion responses to exercise probably indicate 
that the amount of myocardium becoming ischemic during 
exercise is relatively small, possibly as a result of good 
collateral function. Because the prognosis of such a patient 
appears excellent, even in the presence of triple vessel dis•
ease (10), it can be argued that catheterization would not 
provide critically important information above that provided 
by the noninvasive studies. Although the question regarding 
the advisability of coronary angiography cannot be defini•
tively answered given existing data, it seems reasonable to 
conclude that coronary angiography is not routinely indi•
cated in all patients with coronary atherosclerotic disease 
wishing to participate in competitive sports. 
III. Recommendations 
I. Patients in the low risk category can participate in low 
intensity competitive sports (class I.B). However, it is 
the consensus of the members of this Task Force that in 
general it is prudent to recommend that a patient who 
has coronary atherosclerotic disease refrain from partic•
ipating in high to moderate intensity competitive sports. * 
2. Patients in the moderate or high risk category should be 
discouraged from participation in all competitive sports. 
However, selected subjects may engage in some low 
intensity competitive sports (class I.B). 
We recommend that patients who are allowed to en•
gage in low intensity competitive sports (class I.B) undergo 
frequent medical evaluations. These should include phy•
sician contact at least every 6 months and probably a 
yearly exercise test as well. We also recommend that 
these patients be informed of the nature of prodromal 
symptoms and be encouraged to contact their physician 
if such symptoms appear to increase. Physicians should 
be aware that competitive athletes may deny, ignore or 
minimize new symptoms that appear during exertion. 
During follow-up evaluations a patient might be re•
classified depending on changes in the exercise response 
as a result of exercise conditioning or therapy; however, 
there is no conclusive evidence that such changes sub•
stantially alter the risks imposed by competitive sports. 
3. Patients who have recently had coronary revasculariza•
tion (coronary artery bypass graft surgery and balloon 
*The Task Force recognized that there may be unusual clinical char•
acteristics of the patient or the competition that would result in the justifiable 
modification of this recommendation. We also wish to emphasize that we 
are not advising against participation on a recreational, as opposed to a 
competitive, level of athletic activity or against dynamic exercise training 
for its general beneficial effects. 
1224 TASK FORCE V 
ISCHEMIC HEART DISEASE 
angioplasty) or myocardial infarction should follow the 
same recommendations for patients in the moderate or 
high risk, although data relating to risk stratification have 
not been developed. 
4. Patients, after a suitable period of recuperation following 
an acute myocardial infarction, coronary revasculariza•
tion or balloon angioplasty (6 months to I year, de•
pending on severity) and after definition of risk level is 
completed, should follow the same recommendations as 
just given. 
It must be emphasized that the patient identified as being 
at low risk and who has been advised that he can participate 
in less intense competitive sports cannot be assured that 
such participation will incur no added risk of sudden death. 
Indeed, it is probable that high intensity exercise does pose 
some increased risk (13,14). Thus, the ultimate judgment 
as to whether a patient with coronary artery disease should 
participate in competitive sports must not be based on false 
assurances of absent risk, but on probability estimates. The 
physician can only indicate after testing that the patient 
identified as being at low risk is very unlikely to die as a 
result of athletic competition. The patient, coaches and other 
involved persons must be made aware of the probability 
estimates, with the final decision being based on the mag•
nitude of increased risk, for each specific patient, that is 
worth taking. 
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